相关实验视频
Updated: Jun 13, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
TERT突变和放射性耐受性乳头甲状腺癌的侵袭性组织病理学特征
Ju Yeon Pyo1, Yoon Jin Cha2, SoonWon Hong2
1Department of Pathology, International St. Mary's Hospital, Catholic Kwandong University College of Medicine, Incheon, Korea.
Journal of pathology and translational medicine
|September 11, 2024
概括
抗放射性的乳头甲状腺癌 (PTC) 与端粒酶逆转录酶 (TERT) 促销基因突变有关. 这些突变与激进的组织病理特征和PTC患者的较差结果相关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 放射性 (RI) 切除是乳头甲状腺癌 (PTC) 的标准治疗方法.
- 耐RI的PTC呈现出侵略性行为和不良预后.
- 遗传异常,包括端粒酶逆转录酶 (TERT) 突变,与PTC进展有关.
研究的目的:
- 调查TERT-促进子突变与RI耐火性PTC的临床病理特征之间的关联.
- 为了比较RI-耐火性和RI-响应性PTC之间的遗传特征和组织病理特征.
主要方法:
- 在RI耐火和RI响应PTC组织中分析BRAF V600E和TERT促进基因突变.
- 两组之间临床病理特征的比较,包括组织病理学和免疫组织化学.
主要成果:
- 耐RI的PTC表现出明显的组织病理特征,如小瘤集群,钉特征和高细胞高度与宽度比.
- TERT-促进器突变显著与具有侵略性的临床病理特征相关,包括亡,线粒分裂和转移.
- 在RI耐火性瘤中观察到酸同载体,甲状腺蛋白受体和瘤原蛋白 (VEGF,VEGFR2,NF-κB) 的表达减少.
结论:
- TERT-促进子突变是RI-耐火PTC的一个关键因素.
- 特定的侵略性组织病理学特征,特别是在瘤中心,特征RI-耐火PTC.
- 这些发现突出了侵略性PTC的潜在治疗点和预后标志物.
相关概念视频
Synthesis and Regulation of Thyroid Hormones
4.3K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer-Critical Genes I: Proto-oncogenes
8.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K

